Antiarrhythmic Drugs and Management of Ventricular Arrhythmias

Jul 13, 2016 by in CARDIOLOGY Comments Off on Antiarrhythmic Drugs and Management of Ventricular Arrhythmias

Trial Inclusion criteria Treatment groups (n) Results Secondary prevention Antiarrhythmics versus implantable defibrillators (AVID) (1997) [5] Patients with VF arrest, sustained VT Mean follow-up: 8.2 ± 12.2 months Empiric amiodarone (356), randomized…

read more

Drug-Eluting Stents and Coronary Artery Disease

Jul 13, 2016 by in CARDIOLOGY Comments Off on Drug-Eluting Stents and Coronary Artery Disease

Fig. 24.1 Drug-eluting stent structure composed of a metallic stent, a polymer-based drug delivery platform, and a pharmacologic agent. Various available platforms, polymers, and drug agents are described 24.2 DES…

read more

Pathophysiology of Hypertension

Jul 13, 2016 by in CARDIOLOGY Comments Off on Pathophysiology of Hypertension

Age category (years) 1988–1991 (%) 1999–2000 (%) 8–17 7.3a 9.7b 18–39 5.1 7.2 40–59 27 30.1 >60 57–9 65.4 From Refs. [2] and [3] aThese data were obtained from 1988…

read more

Induction of Valvular Heart Disease by Pharmacological Interventions

Jul 13, 2016 by in CARDIOLOGY Comments Off on Induction of Valvular Heart Disease by Pharmacological Interventions

5-HT2 subtype Distribution/function CNS Periphery Drug-induced hallucinogenic responses Liver, renal mesangium mitogenesis vasoactive (pulmonary/coronary vessels) Anxiety, behaviour, locomotion Adipocyte differentiation, platelet aggregation, enteric neurotransmitter Motor behaviour, anxiety, cerebrovascular tone Drug-induced…

read more
Get Clinical Tree app for offline access